(Q44207622)
Statements
Phase I and pharmacokinetic study of docetaxel in combination with epirubicin and cyclophosphamide in advanced cancer: dose escalation possible with granulocyte colony-stimulating factor, but not with prophylactic antibiotics (English)
S P Ackland
J Smith
S Clarke
M J Millward
1 November 2002